Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04263051
Title Evaluation of UCPVax Plus Nivolumab as Second Line Therapy in Advanced Non Small Cell Lung Cancer (Optim-UCPVax)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Centre Hospitalier Universitaire de Besancon
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
CHU of Besançon Besançon 250000 France Details
CHU Bordeaux Bordeaux France Details
Centre Georges François Leclerc Dijon France Details
Institut de Cancérologie Privé CCGM Montpellier France Details
CH Mulhouse Mulhouse France Details
CHU de Nîmes Nîmes France Details
Institut Jean Godinot Reims France Details
Institut de Cancérologie de l'Ouest Saint-Herblain France Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field